WO2007088874A1 - 幹細胞及び胎児由来の心筋細胞及び予定心筋細胞の精製方法 - Google Patents
幹細胞及び胎児由来の心筋細胞及び予定心筋細胞の精製方法 Download PDFInfo
- Publication number
- WO2007088874A1 WO2007088874A1 PCT/JP2007/051563 JP2007051563W WO2007088874A1 WO 2007088874 A1 WO2007088874 A1 WO 2007088874A1 JP 2007051563 W JP2007051563 W JP 2007051563W WO 2007088874 A1 WO2007088874 A1 WO 2007088874A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cardiomyocytes
- cells
- condition
- cell
- serum
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/99—Serum-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/162,684 US9115342B2 (en) | 2006-01-31 | 2007-01-31 | Method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses |
BRPI0706801A BRPI0706801B8 (pt) | 2006-01-31 | 2007-01-31 | método de purificação de cardiomiócitos ou cardiomiócitos programados derivado de células-tronco ou fetos |
KR1020087020152A KR101348325B1 (ko) | 2006-01-31 | 2007-01-31 | 줄기세포 및 태아에서 유래된 심근세포 및 예정 심근세포의제조방법 |
EP07713734.7A EP1983042B1 (en) | 2006-01-31 | 2007-01-31 | A method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses |
CA2640644A CA2640644C (en) | 2006-01-31 | 2007-01-31 | A method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses |
AU2007210580A AU2007210580B2 (en) | 2006-01-31 | 2007-01-31 | A method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses |
KR20127027002A KR101455144B1 (ko) | 2006-01-31 | 2007-01-31 | 줄기세포 및 태아에서 유래된 심근세포 및 예정 심근세포의 제조방법 |
JP2007556880A JP5312804B2 (ja) | 2006-01-31 | 2007-01-31 | 幹細胞及び胎児由来の心筋細胞及び予定心筋細胞の精製方法 |
IL193095A IL193095A (en) | 2006-01-31 | 2008-07-28 | A method for isolating cardiac myocyte cells or programmed heart myocyte cells derived from stem cells or embryos |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006023770 | 2006-01-31 | ||
JP2006-023770 | 2006-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007088874A1 true WO2007088874A1 (ja) | 2007-08-09 |
Family
ID=38327445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/051563 WO2007088874A1 (ja) | 2006-01-31 | 2007-01-31 | 幹細胞及び胎児由来の心筋細胞及び予定心筋細胞の精製方法 |
Country Status (12)
Country | Link |
---|---|
US (1) | US9115342B2 (ja) |
EP (2) | EP2468851A1 (ja) |
JP (2) | JP5312804B2 (ja) |
KR (2) | KR101348325B1 (ja) |
CN (2) | CN103409368B (ja) |
AU (1) | AU2007210580B2 (ja) |
BR (1) | BRPI0706801B8 (ja) |
CA (1) | CA2640644C (ja) |
IL (1) | IL193095A (ja) |
RU (1) | RU2426784C2 (ja) |
SG (1) | SG169359A1 (ja) |
WO (1) | WO2007088874A1 (ja) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012133945A1 (ja) | 2011-03-30 | 2012-10-04 | 学校法人東京女子医科大学 | 胚性幹細胞から心筋シートを製造する方法 |
JP2013528401A (ja) * | 2010-06-18 | 2013-07-11 | セルラー ダイナミクス インターナショナル, インコーポレイテッド | 透析された血清を有する心筋細胞培地 |
JP2013143968A (ja) * | 2006-01-31 | 2013-07-25 | Daiichi Sankyo Co Ltd | 幹細胞及び胎児由来の心筋細胞及び予定心筋細胞の精製方法 |
JP2014521337A (ja) * | 2011-07-29 | 2014-08-28 | セルラー ダイナミクス インターナショナル, インコーポレイテッド | 幹細胞由来の組織細胞中の代謝成熟 |
KR20170031152A (ko) | 2014-07-16 | 2017-03-20 | 하트 시드 가부시키가이샤 | 신규 미분화 줄기세포 제거 및 심근 순화 정제 배지 |
JPWO2016072519A1 (ja) * | 2014-11-07 | 2017-08-17 | 国立大学法人大阪大学 | 未分化細胞が除去された分化誘導細胞集団、その利用及びその製造方法 |
WO2018074457A1 (ja) * | 2016-10-17 | 2018-04-26 | 学校法人慶應義塾 | 未分化幹細胞除去剤、及び未分化幹細胞除去方法 |
WO2018110654A1 (ja) | 2016-12-15 | 2018-06-21 | Heartseed株式会社 | 未分化幹細胞除去剤及び未分化幹細胞除去方法 |
WO2018225705A1 (ja) | 2017-06-05 | 2018-12-13 | テルモ株式会社 | 細胞培養物の製造方法 |
WO2020067438A1 (ja) | 2018-09-27 | 2020-04-02 | 国立大学法人大阪大学 | 多能性幹細胞由来細胞のシート化方法 |
WO2020067436A1 (ja) * | 2018-09-27 | 2020-04-02 | 国立大学法人大阪大学 | 多能性幹細胞由来細胞の移植片形成方法 |
WO2020067435A1 (ja) * | 2018-09-27 | 2020-04-02 | 国立大学法人大阪大学 | 多能性幹細胞由来細胞のシート化方法 |
WO2024008773A1 (en) | 2022-07-05 | 2024-01-11 | Repairon Gmbh | Differentiation of ipscs in bioreactors |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3354723B1 (en) | 2005-08-29 | 2023-12-13 | Technion Research & Development Foundation Ltd. | Media for culturing stem cells |
DK3441459T3 (da) | 2006-08-02 | 2021-06-07 | Technion Res & Dev Foundation | Fremgangsmåder til ekspansion af embryonale stamceller i en suspensionskultur |
CN102449139B (zh) | 2009-03-30 | 2016-08-24 | 第一三共株式会社 | 对多能性干细胞和心肌细胞以外的分化细胞诱导细胞死亡的方法 |
EP4166652A1 (en) | 2009-11-12 | 2023-04-19 | Technion Research & Development Foundation Ltd. | Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state |
KR101364965B1 (ko) * | 2010-10-06 | 2014-02-18 | (주)차바이오앤디오스텍 | 인간 배아줄기세포 유래 심근세포의 배양 및 정제 방법 |
ES2523903B1 (es) * | 2013-04-30 | 2015-09-09 | Fundación Pública Andaluza Progreso Y Salud | Método de obtención de datos útiles para el diagnóstico diferencial de la fibrosis hepática |
CN105039399A (zh) * | 2014-04-23 | 2015-11-11 | 复旦大学 | 多能干细胞-遗传性心肌病心肌细胞及其制备方法 |
EP3196297B1 (en) | 2014-09-16 | 2020-11-04 | Osaka University | Method for producing cardiomyocyte population from pluripotent stem cells |
JP6622007B2 (ja) * | 2015-05-29 | 2019-12-18 | オリンパス株式会社 | 細胞評価方法 |
US11390851B2 (en) | 2016-06-01 | 2022-07-19 | Miltenyi Biotec B.V. & Co. KG | Process for generation, identification and isolation of human pluripotent stem cell-derived cardiomyocytes and cardiomyocyte subpopulations |
CN106244527B (zh) * | 2016-08-29 | 2019-10-08 | 广东依浦赛生物科技有限公司 | 人源iPS干细胞体外定向分化为心肌细胞的试剂盒及方法 |
CN109153963B (zh) | 2016-11-01 | 2022-06-24 | 泰尔茂株式会社 | 粘附状态的细胞培养物的改变方法 |
CN106754663A (zh) * | 2016-11-30 | 2017-05-31 | 中国人民解放军第三军医大学第三附属医院 | 促进成年哺乳动物心肌细胞存活的体外培养方法及监测成年哺乳动物心肌细胞增殖的方法 |
CN107828721A (zh) * | 2017-11-10 | 2018-03-23 | 山东农业大学 | 一种鸡胚心肌细胞的培养及免疫组织化学鉴定方法 |
CN110904024A (zh) * | 2019-11-13 | 2020-03-24 | 武汉济源高科技有限公司 | 一种悬浮细胞培养中去除死细胞的方法 |
CN111621470B (zh) * | 2020-06-08 | 2023-06-27 | 广东源心再生医学有限公司 | 一种高效低毒的心肌纯化培养基及方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2168763A (en) | 1933-03-23 | 1939-08-08 | Ibm | Record controlled machine with improved serial number controls |
WO2000049137A2 (en) | 1999-02-20 | 2000-08-24 | Intercytex Limited | Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
WO2001048151A1 (fr) | 1999-12-28 | 2001-07-05 | Kyowa Hakko Kogyo Co., Ltd. | Cellules pouvant induire une differenciation dans des cellules du muscle cardiaque |
WO2005090558A1 (en) * | 2004-03-19 | 2005-09-29 | Geron Corporation | Method for making high purity cardiomyocyte preparations suitable for regenerative medicine |
WO2005118784A1 (en) * | 2004-06-01 | 2005-12-15 | Es Cell International Pte Ltd | Improved cardiomyocyte differentiation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2430627A1 (en) * | 2000-11-30 | 2002-12-27 | Stemron, Inc. | Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
US7732199B2 (en) * | 2001-07-12 | 2010-06-08 | Geron Corporation | Process for making transplantable cardiomyocytes from human embryonic stem cells |
CA2453438C (en) * | 2001-07-12 | 2016-04-05 | Geron Corporation | Cells of the cardiomyocyte lineage produced from human pluripotent stem cells |
US20080254003A1 (en) | 2004-12-22 | 2008-10-16 | Robert Passier | Differentiation of Human Embryonic Stem Cells and Cardiomyocytes and Cardiomyocyte Progenitors Derived Therefrom |
CA2640644C (en) * | 2006-01-31 | 2013-11-26 | Asubio Pharma Co., Ltd. | A method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses |
-
2007
- 2007-01-31 CA CA2640644A patent/CA2640644C/en active Active
- 2007-01-31 EP EP20120160317 patent/EP2468851A1/en not_active Withdrawn
- 2007-01-31 CN CN201310348017.1A patent/CN103409368B/zh active Active
- 2007-01-31 EP EP07713734.7A patent/EP1983042B1/en active Active
- 2007-01-31 BR BRPI0706801A patent/BRPI0706801B8/pt active IP Right Grant
- 2007-01-31 SG SG201100658-2A patent/SG169359A1/en unknown
- 2007-01-31 WO PCT/JP2007/051563 patent/WO2007088874A1/ja active Application Filing
- 2007-01-31 US US12/162,684 patent/US9115342B2/en active Active
- 2007-01-31 AU AU2007210580A patent/AU2007210580B2/en active Active
- 2007-01-31 RU RU2008135313A patent/RU2426784C2/ru active
- 2007-01-31 CN CNA200780003957XA patent/CN101374942A/zh active Pending
- 2007-01-31 KR KR1020087020152A patent/KR101348325B1/ko active IP Right Grant
- 2007-01-31 JP JP2007556880A patent/JP5312804B2/ja active Active
- 2007-01-31 KR KR20127027002A patent/KR101455144B1/ko active IP Right Grant
-
2008
- 2008-07-28 IL IL193095A patent/IL193095A/en active IP Right Grant
-
2013
- 2013-04-30 JP JP2013095524A patent/JP5756145B2/ja active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2168763A (en) | 1933-03-23 | 1939-08-08 | Ibm | Record controlled machine with improved serial number controls |
WO2000049137A2 (en) | 1999-02-20 | 2000-08-24 | Intercytex Limited | Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
WO2001048151A1 (fr) | 1999-12-28 | 2001-07-05 | Kyowa Hakko Kogyo Co., Ltd. | Cellules pouvant induire une differenciation dans des cellules du muscle cardiaque |
WO2005090558A1 (en) * | 2004-03-19 | 2005-09-29 | Geron Corporation | Method for making high purity cardiomyocyte preparations suitable for regenerative medicine |
WO2005118784A1 (en) * | 2004-06-01 | 2005-12-15 | Es Cell International Pte Ltd | Improved cardiomyocyte differentiation |
Non-Patent Citations (25)
Title |
---|
CHATHAM JC ET AL., J BIOL CHEM, vol. 270, 1995, pages 7999 - 8008 |
DIFFERENTIATION, vol. 68, 2001, pages 31 - 43 |
DOEVENDANS P.A. ET AL.: "Differentiation of Cardiomyocytes in Floating Embryoid Bodies is Comparable to Fetal Cardiomyocytes", J. MOL. CELL CARDIOL., vol. 32, 2000, pages 839 - 851, XP002267746 * |
FASEB J., vol. 14, 2000, pages 2540 - 2548 |
FASEB J., vol. 17, 2003, pages 740 - 742 |
FISHMAN, M. C., SCIENCE, vol. 294, 2001, pages 1290 - 1291 |
HIDAKA K.: "Es Saibo kara no Shinkin Saibo no Bunka Yudo to Tanri", FUKUOKA ISHI, vol. 95, no. 7, 2004, pages 153 - 159, XP003016175 * |
J CLIN INVEST, vol. 103, March 1999 (1999-03-01), pages 697 - 705 |
J CLIN INVEST., vol. 98, 1996, pages 216 - 224 |
J MOL CELL CARDIOL., vol. 35, 2003, pages 1461 - 1472 |
J. CLIN. INVEST., vol. 103, 1999, pages 697 - 705 |
KHAIRALLAH M ET AL., AM J PHYSIOL HEART CIRC PHYSIOL, vol. 286, 2004, pages H1461 - 1470 |
KLUG MG ET AL., J. CLIN. INVEST., vol. 98, 1996, pages 216 - 224 |
MITALIPOVA ET AL., CLONING, vol. 3, 2001, pages 59 - 67 |
MULLER M ET AL., FASEB J., vol. 14, 2000, pages 2540 - 2548 |
NAT. GENET., vol. 24, 2000, pages 372 - 376 |
PETITTE ET AL., MECH. DEV., vol. 121, 2004, pages 1159 - 1168 |
SASAKI ET AL., STEM CELLS., vol. 23, 2005, pages 1304 - 1313 |
SCHRODER AR ET AL., CELL, vol. 110, 2002, pages 521 - 529 |
See also references of EP1983042A4 |
SUEMORI ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., vol. 345, 2006, pages 926 - 932 |
SUEMORI ET AL., DEV. DYN., vol. 222, 2001, pages 273 - 279 |
TADA ET AL., CURR. BIOL., vol. 11, 2001, pages 1553 |
THOMSON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 92, 1995, pages 7844 |
VRANA K ET AL., PROC. NATL. ACAD. SCI. USA, vol. 100, 2003, pages 11911 - 6 |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013143968A (ja) * | 2006-01-31 | 2013-07-25 | Daiichi Sankyo Co Ltd | 幹細胞及び胎児由来の心筋細胞及び予定心筋細胞の精製方法 |
JP2013528401A (ja) * | 2010-06-18 | 2013-07-11 | セルラー ダイナミクス インターナショナル, インコーポレイテッド | 透析された血清を有する心筋細胞培地 |
US9365826B2 (en) | 2010-06-18 | 2016-06-14 | Cellular Dynamics International, Inc. | Cardiomyocyte medium with dialyzed serum |
WO2012133945A1 (ja) | 2011-03-30 | 2012-10-04 | 学校法人東京女子医科大学 | 胚性幹細胞から心筋シートを製造する方法 |
JP2014521337A (ja) * | 2011-07-29 | 2014-08-28 | セルラー ダイナミクス インターナショナル, インコーポレイテッド | 幹細胞由来の組織細胞中の代謝成熟 |
KR20170031152A (ko) | 2014-07-16 | 2017-03-20 | 하트 시드 가부시키가이샤 | 신규 미분화 줄기세포 제거 및 심근 순화 정제 배지 |
JPWO2016072519A1 (ja) * | 2014-11-07 | 2017-08-17 | 国立大学法人大阪大学 | 未分化細胞が除去された分化誘導細胞集団、その利用及びその製造方法 |
KR20190052096A (ko) | 2016-10-17 | 2019-05-15 | 각고호우징 게이오기주크 | 미분화 줄기세포 제거제, 및 미분화 줄기세포 제거 방법 |
WO2018074457A1 (ja) * | 2016-10-17 | 2018-04-26 | 学校法人慶應義塾 | 未分化幹細胞除去剤、及び未分化幹細胞除去方法 |
JPWO2018074457A1 (ja) * | 2016-10-17 | 2019-07-18 | 学校法人慶應義塾 | 未分化幹細胞除去剤、及び未分化幹細胞除去方法 |
WO2018110654A1 (ja) | 2016-12-15 | 2018-06-21 | Heartseed株式会社 | 未分化幹細胞除去剤及び未分化幹細胞除去方法 |
WO2018225705A1 (ja) | 2017-06-05 | 2018-12-13 | テルモ株式会社 | 細胞培養物の製造方法 |
WO2020067438A1 (ja) | 2018-09-27 | 2020-04-02 | 国立大学法人大阪大学 | 多能性幹細胞由来細胞のシート化方法 |
WO2020067436A1 (ja) * | 2018-09-27 | 2020-04-02 | 国立大学法人大阪大学 | 多能性幹細胞由来細胞の移植片形成方法 |
WO2020067435A1 (ja) * | 2018-09-27 | 2020-04-02 | 国立大学法人大阪大学 | 多能性幹細胞由来細胞のシート化方法 |
JPWO2020067438A1 (ja) * | 2018-09-27 | 2021-08-30 | 国立大学法人大阪大学 | 多能性幹細胞由来細胞のシート化方法 |
JPWO2020067436A1 (ja) * | 2018-09-27 | 2021-08-30 | 国立大学法人大阪大学 | 多能性幹細胞由来細胞の移植片形成方法 |
JPWO2020067435A1 (ja) * | 2018-09-27 | 2021-09-09 | 国立大学法人大阪大学 | 多能性幹細胞由来細胞のシート化方法 |
WO2024008773A1 (en) | 2022-07-05 | 2024-01-11 | Repairon Gmbh | Differentiation of ipscs in bioreactors |
Also Published As
Publication number | Publication date |
---|---|
JP2013143968A (ja) | 2013-07-25 |
KR101455144B1 (ko) | 2014-10-27 |
EP1983042B1 (en) | 2017-03-15 |
CN103409368B (zh) | 2016-05-25 |
SG169359A1 (en) | 2011-03-30 |
AU2007210580A1 (en) | 2007-08-09 |
IL193095A (en) | 2015-06-30 |
KR20120123608A (ko) | 2012-11-08 |
RU2426784C2 (ru) | 2011-08-20 |
KR20080097197A (ko) | 2008-11-04 |
BRPI0706801A2 (pt) | 2011-04-05 |
BRPI0706801B8 (pt) | 2021-05-25 |
BRPI0706801B1 (pt) | 2020-04-07 |
EP1983042A1 (en) | 2008-10-22 |
CA2640644C (en) | 2013-11-26 |
AU2007210580B2 (en) | 2012-10-11 |
US9115342B2 (en) | 2015-08-25 |
KR101348325B1 (ko) | 2014-01-08 |
JPWO2007088874A1 (ja) | 2009-06-25 |
CN103409368A (zh) | 2013-11-27 |
EP1983042A4 (en) | 2009-06-17 |
RU2008135313A (ru) | 2010-03-20 |
US20090275132A1 (en) | 2009-11-05 |
CN101374942A (zh) | 2009-02-25 |
IL193095A0 (en) | 2009-02-11 |
EP2468851A1 (en) | 2012-06-27 |
CA2640644A1 (en) | 2007-08-09 |
JP5312804B2 (ja) | 2013-10-09 |
JP5756145B2 (ja) | 2015-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5756145B2 (ja) | 幹細胞及び胎児由来の心筋細胞及び予定心筋細胞の精製方法 | |
Ali et al. | Derivation of type II alveolar epithelial cells from murine embryonic stem cells | |
JP5523830B2 (ja) | 心筋細胞の細胞塊作製方法及び当該心筋細胞塊の用途 | |
US9994822B2 (en) | Cardiomyocyte differentiation | |
CN101037669A (zh) | 一种从人胚胎干细胞诱导肝细胞的方法 | |
Lü et al. | Bioreactor cultivation enhances NTEB formation and differentiation of NTES cells into cardiomyocytes | |
WO2010114136A1 (ja) | 多能性幹細胞及び心筋細胞以外の分化細胞に対する細胞死誘導方法 | |
AU2012227337B2 (en) | A method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses | |
JP2022540579A (ja) | cP1Pまたはその薬学的に許容可能な塩を有効成分として含む幹細胞増殖促進用組成物 | |
WO2022211054A1 (ja) | 卵巣体細胞様細胞の製造方法、及び霊長類多能性幹細胞を卵巣体細胞様細胞に分化誘導する方法 | |
Kuehn | Characterization of Embryonic Stem Cell-Differentiated Cells as Mesenchymal Stem Cells | |
van der Heyden et al. | Culturing and Differentiation of Embryonic and Adult Stem Cells for Heart Research and Transplantation Therapy | |
Bauwens | A scalable bioprocess for generating embyronic stem cell derived cardiomyocytes | |
Hudson et al. | IWP-4 | |
Sun et al. | Human Embryonic Stem Cell‐Derived Cardiomyocytes for Cell Therapy and Drug Discovery | |
WO2009052209A2 (en) | Isolation of stem cells and effective control of contamination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2007556880 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 193095 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2640644 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200780003957.X Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2007713734 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007713734 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020087020152 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007210580 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4551/CHENP/2008 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2008135313 Country of ref document: RU Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2007210580 Country of ref document: AU Date of ref document: 20070131 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12162684 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0706801 Country of ref document: BR Kind code of ref document: A2 Effective date: 20080731 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020127027002 Country of ref document: KR |